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Effects of acceptance of disability on death
or dialysis in chronic kidney disease
patients: a 3-year prospective cohort study
Hsin-Hung Chiang1,2†, Hanoch Livneh3†, How-Ran Guo4,5†, Mei-Ling Yen1 and Tzung-Yi Tsai4,6,7*
Abstract
Background: Acceptance of disability (AOD) is a useful construct that assesses the ability of a patient to
psychologically cope with chronic diseases, but its effect on long-term outcomes of patients with chronic kidney
disease (CKD) remains unclear. This study aimed to evaluate the relation between AOD level and clinical outcomes
in a cohort of CKD patients in Taiwan.
Methods: 262 CKD patients without dialysis at a hospital in Taiwan were consecutively recruited, from 2010 to
2011, and followed up for 3 years. At enrollment, demographic and clinical data were obtained, including baseline
level measurement of AOD, using the Acceptance of Disability Scale-Revised (AODS-R). During follow-up, the
authors assessed the effect of AOD on progression to dialysis and all-cause mortality by using Cox proportional
hazard regression analysis.
Results: Of the patients included in the analyses, 145 (55.3 %) whose total scores of AOD were below the median
(86.00) were regarded as having low AOD at enrollment. At the end of 3-year follow-up, 25 have died and 57
initiated dialysis. Participants with low AOD were more likely to have the composite end-point of progression to
dialysis or death (adjusted hazard ratios [AHR] = 1.89, 95 % confidence interval [CI]: 1.18-3.20). In addition, CKD stage
at IV or above and hemoglobin level were found to be associated with the occurrence of the composite end-point.
Conclusion: AOD was associated with an increased risk for poor clinical outcomes, thus suggesting that prompt
awareness and management of the psychological reactions may improve clinical outcomes of patients with CKD.
Keywords: Acceptance of disability, Chronic kidney disease, Dialysis, Mortality, Taiwan
Background
Chronic kidney disease (CKD) has become a global pub-
lic health burden over the past decades [1]. Due to the
irreversible nature of CKD, most patients gradually
progress to end-stage renal disease (ESRD) and require
dialysis or renal transplantation. The global ESRD
prevalence is estimated to continue to rise at an annual
rate of 7 % and exceed 2 million by 2010 [2]. In Taiwan,
where the prevalence is among the highest in the world,
ESRD has put a substantial burden on healthcare re-
sources. A governmental report in 2012 revealed that
while Taiwanese ESRD patients constituted less than
0.3 % of the population, they took up about 7 % of the
total healthcare budgets, surpassing that of cancer
patients [3].
In addition to the enormous economic impact, CKD is
also a significant public health burden. A cohort study in
Taiwan of 462,293 subjects reported that nearly 10.3 %
of deaths were due to CKD, and that 40 % of CKD
deaths occurred in patients younger than 65 years-old
[4]. Therefore, CKD patients typically experience many
symptoms over a prolonged period of time and are fre-
quently diagnosed with psychiatric disorders, such as de-
pression. A meta-analysis showed that depression was
common in patients with CKD, with a pooled prevalence
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of 21 %, approximately two- to four-fold higher than
that in the general population [5]. Furthermore, CKD
patients with depressive symptoms have over three-fold
increased risk of death relative to those without the
symptoms [6], suggesting that the improvement of psy-
chological adjustment would prolong the survival rate.
In general, a psychological intervention program for
patients with chronic diseases appears to help them to
accept their disabilities, learn to better cope and live
with their diseases, and adapt to the ensuing physical
and psychosocial sequelae [7]. Acceptance of disability
(AOD) is considered a key factor that accounts for this
improvement in psychosocial adjustment [8, 9]. AOD is
associated with viewing one’s disability as a manageable
barrier that does not devalue life or minimize one's
remaining abilities, and this can be achieved through
personal coping efforts and the realization that one can
successfully overcome many of life’s restrictions and lim-
itations [10]. To specifically measure AOD, Linkowski
developed an AOD scale based on concepts inherent in
the notion of acceptance of loss [11]. Numerous studies
have used this scale to examine disease and disability ac-
ceptance among patients with chronic conditions such
as Ehlers-Danlos syndrome [12], diabetes [13], spinal
cord injury [8], and stroke [14]. Overall, these results in-
dicated that the higher the level of disability acceptance,
the more successful is the coping with the condition and
the better is the perceived quality of life of the patients.
Nonetheless, the long-term effects of AOD on clinical
outcomes in patients with chronic diseases remain un-
clear. To fill this gap, we conducted a study to examine
the relationships between AOD and two clinical out-
comes, namely, progression to dialysis and all-cause
mortality, among CKD patients in Taiwan.
Methods
Study design and population
We recruited consecutive CKD patients from either out-
patient or inpatient departments, located at a hospital in
southern Taiwan, from January 2010 to December 2011.
The eligibility criteria at baseline included: (1) age of at
least 20 years; (2) no physician-based diagnosis of alco-
hol abuse, dementia, psychosis, or depression; (3) ability
to express opinions in Mandarin or Taiwanese; (4) diag-
nosis of CKD by a physician, but not yet undergoing dia-
lysis; and (5) willingness to consent to a blood test on
the survey date. Before enrollment, all participants re-
ceived detailed written and verbal information regarding
the aims and protocol of the study and signed informed
consents. To ensure participants’ anonymity, all ques-
tionnaires were marked with encryption code to facili-
tate data analysis, but lacking any personal identifiers.
This study was approved by the institutional review
board of the Dalin Tzuchi Hospital, Buddhist Tzuchi
Medical Foundation, Taiwan (No. B10201011).
Measures
Assessment of AOD level
AOD was assessed by the revised version of the AOD
scale (AODS-R), developed by Groomes and Linkowski
[9]. It is a 32-item questionnaire that was developed as a
brief multidimensional self-reporting instrument for the
assessment of four domains: enlargement of scope of
values, subordination of physique, containment of dis-
ability effects, and transformation from comparative to
asset values. Each item is rated on a 4-point Likert scale,
ranging from 1 (strongly disagree) to 4 (strongly agree).
Thus, the AODS-R total score ranges from 32 to 128,
where higher scores indicate a higher level of disability
acceptance. Ten of the items address positive values.
The remaining 22 items address negative values. A prin-
cipal component analysis extracted four factors corre-
sponding to the psychometric characteristics of the
original version, thus providing support for the concep-
tual validity of the AODS-R [9]. Previous studies have
demonstrated that the AODS-R has good internal
consistency in different groups of patients with chronic
illnesses and disabilities [14–16]. The data collected in
our study yielded a Cronbach’s α of 0.92 for the scale.
Covariates
Patient interviews and reviews of medical records were
performed to collect the information on demographic
and clinical characteristics at enrollment. The demo-
graphic data considered included sex, age, marital status,
educational level, job status, living status, religious be-
liefs, monthly income, and certain lifestyle factors, such
as use of alcohol and tobacco, exercise habits, and pres-
ence of sleep disturbances. Alcohol consumption was re-
corded as “less than 2 times per week” or “at least two
times per week”; smoking status was recorded as “non-
smoker” or “current or ex-smoker.” Those who exercised
regularly (that is, weekly) were regarded as having “exer-
cise habits”. Sleep disturbance was defined as waking up
at night more than twice without external factors during
the week before the interview. Clinical characteristics in-
cluded the presence of a chronic disease (i.e. at least one
of the following: diabetes mellitus, hypertension, heart
disease, or stroke), CKD stage, hemoglobin level, and
serum albumin level.
Primary clinical outcomes
The primary clinical outcomes comprised death (all-
cause mortality) and progression to dialysis. The date of
initiation of dialysis was determined during monthly
face-to-face interviews at outpatient clinics or by tele-
phone. If the researchers suspected that a patient has
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died, they contacted the participant's family directly for
confirmation, and to obtain the date of death. All par-
ticipants were followed from the date of enrollment
until death or the end of 3-year follow-up, whichever
came first.
Statistical analysis
After using the median of the range of obtained AOD
scores as the cut-off, we split participants into two
groups: “high” and “low” AOD levels. The mean, stand-
ard deviation (SD), and percentage of demographic and
disease data between the two AOD groups were then
compared employing two-sample t tests for continuous
variables and chi square tests for categorical variables.
Next, incidence rates of adverse events were presented
as the number of cases per 1000 person-months (PMs).
Finally, we applied the Cox proportional hazard model
to compute the AHR and its 95 % CI for primary out-
comes associated with a low AOD level. Assumptions of
the proportional hazard models were confirmed by
using log-log plots and cumulative Schoenfeld residual
plots. All inferential analyses were two-tailed using an
alpha level of 0.05, and all statistical analyses were
performed using SAS version 9.3 (SAS Institute Inc.,
Cary, NC, USA).
Results
Basic characteristics of participants
Of the 267 consecutive qualified CKD patients, 3 refused
to participate in the follow-up survey and 2 were ex-
cluded because primary outcomes occurred within the
first month of follow-up, leaving insufficient time for the
establishment of temporal relationship. Therefore, data
on 262 patients were included in the final analysis. The
mean age of patients was 64.3 years, and 61.5 % were
men (Table 1). The mean AOD score was 85.02 (± 5.36),
and 55.3 % (145/262) of the participants scored at a low
AOD level (at AOD score below the median of 86.00).
Patients with a low AOD level were more likely to
have a low educational level (p = 0.04), did not exercise
regularly (p = 0.01), had sleep disturbance (p = 0.02),
were diagnosed with CKD stage IV or above (p = 0.03),
had concomitant chronic diseases (p = 0.04), and had a
low hemoglobin level (p = 0.02) (Table 1).
Incidence and hazard ratios for death and initiation of
dialysis
Overall, the mean follow-up was 31.17 months, and 82
patients (31.3 %) either died (n = 25, 9.5 %) or progressed
to dialysis (n = 57, 21.8 %). CKD patients with low AOD
were more likely to progress to dialysis (27.6 % vs.
14.5 %; p = 0.03) and die (13.1 % vs. 5.1 %; p = 0.01).
After adjustment for the significant factors in the univar-
iate analysis, we found that lower AOD was associated
with an elevated but non-significant risk of death
(AHR = 1.82; 95 % CI: 0.90–4.90). In contrast, AOD
level was associated with a statistically significant risk of
progression to dialysis (AHR = 1.95; 95 % CI: 1.04–3.34)
(Table 2).
Multivariable analysis of factors associated with the
composite end-point
When we combined death and progression to dialysis as
a composite end-point, we found that low AOD score
was associated with an increased risk (AHR = 1.89; 95 %
CI: 1.18–3.20) after adjustment for potential confound-
ing factors. The other independent risk factors included
CKD stage IV or above (AHR = 1.82; 95 % CI: 1.21–
4.21), and a low hemoglobin level (AHR = 0.81; 95 % CI:
0.70–0.92) (Table 3).
Discussion
The present 3-year longitudinal follow-up study of CKD
patients who were not yet on dialysis showed that those
with low AOD had an increased risk for progression to
dialysis, which is consistent with findings of previous
studies that CKD patients who experience negative emo-
tions tend to also experience worse clinical manifesta-
tions [5, 17]. A study by Fischer and colleagues [18] also
found that depressive symptoms predicted a 15 %
greater risk of progression to ESRD among patients with
CKD, but this increased risk did not reach statistical sig-
nificance. This discrepancy in findings could be partially
attributed to difference in potential confounders mea-
sured in both analyses. It could also be attributed to dif-
ferent definitions of disease stage between the two
studies since Fischer et al. [18] directly used the value of
glomerular filtration rate (GFR) to evaluate the disease
severity of CKD, and not classification of stage.
There are at least several potential reasons for the as-
sociation between low AOD and poor clinical outcomes.
First, negative emotions, such as depression, are known
to be associated with treatment non-adherence [19] and
unhealthy lifestyle such as malnutrition and physical in-
activity that may accelerate the decline in serum albu-
min and thus progression of CKD [20, 21]. Systematic
inflammation induced by a distressed mood may be an-
other plausible explanation; many studies demonstrated
that CKD patients with depressive symptoms had higher
levels of circulating inflammatory markers, such as
interlukin-6 (IL-6), tumor necrosis factor-α (TNF-α),
and C-reactive protein (CRP), all of which play import-
ant roles in the pathogenesis of cardiovascular diseases
and worsen the prognosis of CKD [5, 22]. Third, nega-
tive mood influences the sensitivity to glucocorticoid
hormones and leads to immunosuppression through ac-
tivation of the hypothalamic-pituitary-adrenal (HPA)
axis [23], which substantially increases the risk of acute
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Table 1 Demographic and clinical characteristics of all CKD patients with low and high AOD
Variables All subjects (n = 262) Low AOD (n = 145) High AOD (n = 117) p
Demographic characteristics
Age (years) 64.26 ± 13.25 64.08 ± 12.14 65.29 ± 14.25 0.47
Gender
Male 161 (61.5) 83 (57.2) 78 (66.7) 0.12
Female 101 (38.5) 62 (42.8) 39 (33.3)
Educational level
High(≥12th grade) 66 (25.2) 45 (31.0) 51 (43.6) 0.04*
Low(<12th grade) 196 (74.8) 100 (69.0) 66 (65.4)
Marital status
Single 18 (6.9) 12 (8.3) 6 (5.1) 0.32
Married 244 (93.1) 133 (91.7) 111 (94.9)
Job status
Employed 73 (27.9) 43 (29.7) 30 (25.6) 0.47
Unemployed 189 (72.1) 102 (70.3) 87 (74.4)
Living status
Alone 22 (8.4) 12 (8.3) 10 (8.6) 0.92
Cohabitating 239 (91.6) 133 (91.7) 106 (91.4)
Monthly income★
≥ NT$30,001 50 (19.1) 27 (18.6) 23 (19.7) 0.83
≤ NT$30,000 212 (80.9) 118 (81.4) 94 (80.3)
Religious beliefs
Yes 223 (85.1) 123 (84.8) 100 (85.5) 0.88
No 39 (14.9) 22 (15.2) 17 (14.5)
Alcohol drinking
Low (≤ 1 times/week) 247 (94.3) 136 (93.8) 111 (94.9) 0.71
High (≥ 2 times/week) 15 (5.7) 9 (6.2) 6 (5.1)
Cigarette smoking
Yes 107 (40.8) 59 (40.7) 48 (41.0) 0.95
No 155 (59.2) 86 (59.3) 69 (59.9)
Regular exercise
Yes 171 (65.3) 85 (58.6) 86 (73.5) 0.01*
No 91 (34.7) 60 (41.4) 31 (26.5)
Sleep disturbance
Yes 166 (63.4) 117 (80.7) 79 (67.5) 0.02*
No 96 (36.6) 28 (19.3) 38 (32.5)
Clinical characteristics
CKD stage
Stage I, II, or III 104 (39.7) 49 (33.8) 55 (47.0) 0.03*
Stage IV or V 158 (60.3) 96 (66.2) 62 (53.0)
Other chronic diseases
≤ 1 90 (34.4) 42 (29.0) 48 (41.0) 0.04*
≥ 2 172 (65.6) 103 (71.0) 69 (59.0)
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infection and mortality [24]. Therefore, the implementa-
tion of standardized psychosocial assessment and of pa-
tient care procedures, in routine care, may help early
referral of CKD patients for further therapeutic interven-
tions that could delay the progression of disease.
The findings of our study revealed that CKD patients
with stage IV and above had a higher risk of poor clinical
outcomes, and this is compatible with a large
population-based study showing that late-stage CKD
was a significant risk factor for mortality among renal
failure patients in Taiwan [25]. It could be argued that
patients with advanced stage of kidney failure typically
experience higher predisposition to cardiovascular dis-
eases or renal-related co-morbidities, and consequently
are at an elevated risk of death [26]. Additionally, the
present study showed that a one-unit increase in
hemoglobin was associated with a 19 % decrease in the
risk for the composite end-point, and this is compatible
with findings of a previous study [27]. Patients with de-
creased levels of hemoglobin are more prone to anemia,
which can evoke left ventricular hypertrophy and cardio-
vascular mortality [28]. Therefore, subnormal hemoglobin
levels in CKD patients should be recognized and managed
at earlier stages of disease progression.
Strengths and limitations
In contrast to the available data on the influence of psy-
chological responses on clinical outcomes in renal dis-
ease patients who receive dialysis treatment, the findings
from this 3-year prospective cohort study focused on
CKD subjects who did not yet undergone dialysis. Our
findings provide strong support for the importance of
psychological factors, such as disability acceptance, in af-
fecting clinical outcomes, thus supporting usefulness of
therapeutic regimens geared at promoting psychosocial
adjustment to CKD. Several limitations, nevertheless,
should be considered when interpreting the results of
the present study. First, all participants were drawn from
a single hospital in southern Taiwan, so the results might
not be generalizable to other CKD subjects, especially
those from non-Chinese populations. However, previous
research has also often been limited by such factors as
subjects' ethnicity, geographical location, nationality and
the nature of the medical data available, suggesting that
this limitation is not unique to our study. Second, in this
study, we only assessed AOD at the beginning of the
follow-up time period. It is likely that AOD scores could
change over time. However, failure to consider the effect
of time-varying predictors on end-points would tend to
underestimate, rather than overestimate, an association
Table 1 Demographic and clinical characteristics of all CKD patients with low and high AOD (Continued)
Hemoglobin (g/dL) 11.12 ± 2.04 10.86 ± 2.11 11.43 ± 1.89 0.02*
Serum creatine (mg/dL) 4.97 ± 1.58 5.13 ± 5.76 4.77 ± 5.97 0.62
Serum albumin (g/dL) 3.51 ± 0.51 3.46 ± 0.57 3.57 ± 0.41 0.07
Abbreviation: AOD, Acceptance of disability
Data is presented as mean ± SD or n (%)
★US $1 = 30.23 NTD at the study time period
*p < 0.05
Table 2 Effect of AOD on risk of death or progression to
dialysis in CKD patients
Event (n) Incidence** AHR†(95 % CI)
Low AOD High AOD Low AOD High AOD
Death 19 6 4.51 1.49 1.82 (0.90-4.90)
Dialysis 40 17 9.43 4.33 1.95 (1.04-3.34)
Abbreviations: AOD, Acceptance of disability; AHR, adjusted hazard ratios
**Incidence is presented as cases per 1000 person-months
†Adjusted for the educational level, exercise habit, CKD stage, sleep
disturbance, chronic disease, and hemoglobin level
Table 3 Multivariable analysis of factors associated with the
composite endpoint of death and progression to dialysis
Variables CHR (95 % CI) AHR†(95 % CI)
AOD
Low 2.34 (1.51-3.49)* 1.89 (1.18-3.20)*
High - -
Educational level
Low 0.98 (0.49-1.38) 1.01 (0.58-1.71)
High - -
Other chronic diseases
≤ 1 1.34 (0.82-2.17) 1.31 (0.81-2.13)
≥ 2 - -
Regular exercise
No 0.89 (0.41-1.57) 0.97 (0.50-1.44)
Yes - -
Sleep disturbance
Yes 1.17 (0.74-2.84) 1.04 (0.94-2.98)
No - -
CKD stage
Stage IV or V 2.26 (1.70-5.36)* 1.82 (1.21-4.21)*
Stage I, II, or III - -
Hemoglobin (g/dL) 0.78 (0.63-0.88)* 0.81 (0.70-0.92)*
Abbreviations: AOD, Acceptance of disability; CHR, crude hazard ratios; AHR,
adjusted hazard ratios
†Adjusted for the other variables in this table
*p < 0.05
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[29], so AOD is more likely to increase rather than de-
crease over time [14]. Therefore, this potential concern
is not likely to influence the conclusions of our study.
Third, we assessed sleep disturbance using a single-item
question, so the psychometric soundness of such an as-
sessment may be suspect and thus must be interpreted
cautiously.
Implications
The findings of this study have important implications
for future research and clinical practice. Given that our
data were drawn from a single hospital may restrict the
generalizability of these findings. Accordingly, it is rec-
ommended, that larger community-based studies, with a
comprehensive battery of psychological and clinical mea-
sures, be employed to identify undiagnosed patients in
order to validate our findings. Furthermore, longitudinal
measurement of disability acceptance should be imple-
mented to verify if the present findings are consistent
across the process of psychological adaptation to CKD.
As far as clinical practice is concerned, the findings of
this study indicate that AOD level could serve as an in-
dependent risk factor for poor clinical outcomes, sug-
gesting that the AODS-R scale could be judiciously
applied when assessing reactions towards life with a
chronic illness, such as CKD. Finally, the present find-
ings, especially if supported by future research, also
point to the importance of routinely observing patients
for negative psychological responses, and, if feasible, in-
stituting appropriate interventions for routine clinical
practice.
Conclusion
We found that low AOD was independently associated
with an increased risk of poor clinical outcomes. In
addition, patients with CKD stage IV and above and
those with low hemoglobin levels also had an elevated
risk of poor clinical outcomes. These findings, together
with previous results, provide further support that poor
psychosocial adaptation, as assessed by low levels of dis-
ability acceptance, may have an imperative role in CKD
prognosis. Therefore, it may be tentatively recom-
mended that routine psychological screening, through
the use of AOD at diagnosis of CKD, followed by moni-
toring and timely management of its progression, could
be beneficial to patients with CKD.
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